Clotilde Théry
From Wikipedia, the free encyclopedia
Oxford University, United Kingdom
Columbia University, New York
Institut Curie, France
Clotilde Théry | |
|---|---|
 Théry in 2017 | |
| Education | College de France, Paris (PhD, 1991) Oxford University, United Kingdom Columbia University, New York Institut Curie, France |
| Known for | Research on the immunology of extracellular vesicles; President, International Society for Extracellular Vesicles |
| Awards | International Society for Extracellular Vesicles Special Achievement Award (2014) |
| Scientific career | |
| Fields | Cellular biology, molecular biology, immunology |
| Institutions | Institut Curie |
| Academic advisors | S. Amigorena |
| Website | science.institut-curie.org/ Théry Lab |
Clotilde Théry is a professor and INSERM director of research (DR2) at Institut Curie in Paris, France.[1][2] She is president of the International Society for Extracellular Vesicles (ISEV), where she previously served as founding secretary general and as editor-in-chief of the Journal of Extracellular Vesicles. She is the team leader of the group "Extracellular Vesicles, Immune Responses and Cancer" within the INSERM Unit 932 focusing on "Immunity and Cancer." Théry researches extracellular vesicles that are released by immune and tumor cells, including exosomes that originate in the multivesicular body.
After earning a PhD in France, Théry completed her first post-doctoral fellowship in the United Kingdom and the United States, focusing on the developmental biology of the nervous system. Upon returning to France, Théry took up the topic of cell biology of immune responses at Institut Curie.
Théry began studying exosomes in 1998, at a time when extracellular vesicles (EVs) were largely regarded as unimportant or even artifacts.[3] In 2007, Théry's current team on Extracellular Vesicles, Immune responses and Cancer was started at Institut Curie, which is now a member of the PSL Research University.
